Leptin tA Ovine

Leptin Antagonist Triple Mutant Ovine Recombinant
Shipped with Ice Packs
In Stock

Description

Production and Purity

Leptin tA Ovine is produced via recombinant expression in E. coli, followed by proprietary chromatographic purification. Its high purity is validated by:

MethodResult
SDS-PAGESingle band at ~48 kDa (indicating monomeric PEGylation) .
Gel FiltrationElution volume consistent with >200 kDa (PEG-induced size increase) .
Purity>95% as determined by gel filtration and SDS-PAGE .

The protein is supplied as a lyophilized powder, requiring reconstitution in sterile water or 0.4% NaHCO₃ (pH 8) to concentrations ≥100 µg/ml .

In Vitro Activity

Leptin tA Ovine inhibits leptin-induced proliferation of BAF/3 cells expressing human ObR (long isoform). Its activity is 6–8× lower than non-PEGylated antagonists due to steric hindrance from PEGylation .

In Vivo Effects

Despite reduced in vitro potency, PEGylation confers prolonged systemic exposure, leading to significant weight gain in rodent models via increased food intake. This contrasts with non-PEGylated antagonists, which show transient effects .

Applications in Research and Preclinical Studies

Leptin tA Ovine is utilized to:

  1. Study Leptin Receptor Signaling: Dissect ObR activation mechanisms using competitive antagonists .

  2. Model Obesity and Metabolic Disorders: Induce hyperphagia and weight gain in rodent models to investigate leptin resistance .

  3. Evaluate PEGylation Effects: Compare pharmacokinetics of PEGylated vs. non-PEGylated antagonists in vivo .

Comparative Analysis with Native Leptin

ParameterLeptin tA OvineNative Ovine Leptin
Receptor BindingCompetes for ObR binding (antagonist)Activates ObR (agonist)
Biological RoleInhibits leptin signalingRegulates energy balance, growth, and metabolism
PEGylation20 kDa PEG enhances half-lifeNon-PEGylated
Therapeutic PotentialObesity, leptin-sensitive disordersMetabolic disorders (e.g., leptin deficiency)

Product Specs

Description
Leptin Antagonist Triple Mutant Ovine Recombinant is a single, non-glycosylated polypeptide chain with 146 amino acids, including an additional alanine at the N-terminus. It has a molecular mass of approximately 16 kDa. The Leptin protein was mutated, resulting in the L39A/D40A/F41A mutant. This recombinant protein was purified using proprietary chromatographic techniques.
Physical Appearance
White, lyophilized powder.
Formulation
The protein was lyophilized from a concentrated solution (0.65 mg/ml) containing 0.003 mM sodium bicarbonate.
Solubility
Reconstitute the lyophilized Leptin Antagonist Triple Mutant Ovine Recombinant in sterile water or sterile 0.4% sodium bicarbonate adjusted to a pH of 8. The minimum concentration should be 100 µg/ml. This solution can be further diluted with other aqueous solutions.
Stability
Lyophilized Leptin Antagonist Triple Mutant Ovine Recombinant remains stable at room temperature for several weeks. However, it is recommended to store it desiccated below -18°C for long-term storage. After reconstitution to a concentration greater than 0.1 mg/ml and up to 2 mM, followed by filter sterilization, it can be stored at 4°C or room temperature for several weeks. This stability makes it suitable for extended infusion studies using osmotic pumps. For lower concentrations, adding a carrier protein like 0.1% HSA or BSA is suggested. Avoid repeated freeze-thaw cycles.
Purity
Purity exceeds 98.0% as determined by: (a) Gel filtration analysis. (b) SDS-PAGE analysis.
Biological Activity
THE BioTek's Leptin Antagonist Triple Mutant Ovine Recombinant effectively inhibits leptin-induced proliferation of BAF/3 cells stably transfected with the long form of the mouse leptin receptor. It also inhibits various leptin effects in several in vitro bioassays.
Protein Content
Protein quantification was performed using UV spectroscopy at 280 nm. An absorbency value of 0.21 was used as the extinction coefficient for a 0.1% (1 mg/ml) solution at pH 8.0. This value is calculated by the PC GENE computer analysis program for protein sequences (IntelliGenetics).
Source
Escherichia coli.
Amino Acid Sequence
The sequence of the first five N-terminal amino acids was determined and was found to be Ala-Val-Pro-Ile-Arg.

Q&A

What is leptin and why are ovine models used in leptin research?

Leptin is an adipokine secreted by adipose tissue that conveys information on energy stores and regulates both neuroendocrine function and energy homeostasis . Ovine models are particularly valuable in leptin research because sheep exhibit physiological leptin resistance as a seasonal adaptation, unlike the pathological state observed in humans . This natural phenomenon allows researchers to study leptin sensitivity and resistance mechanisms under controlled conditions. Additionally, sheep have metabolic characteristics that make certain findings more translatable to human physiology than rodent studies, particularly regarding seasonal adaptations and energy regulation.

How does leptin concentration vary seasonally in sheep?

Leptin concentrations in sheep demonstrate significant seasonal variations correlated with photoperiod. During long-day (LD) seasons (summer months), leptin plasma concentrations increase by approximately 180% compared to short-day (SD) seasons (winter months) . This seasonal variation represents a physiological adaptation that allows sheep to increase food intake and store energy during periods of food abundance, despite high leptin levels which would normally suppress appetite. During autumn and winter, sheep exhibit physiological sensitivity to leptin, with appetite adjusting proportionally to nutritional status .

What are the primary effects of leptin on hypothalamic-pituitary axes in sheep?

Leptin affects multiple hypothalamic-pituitary axes in sheep, with significant impacts on both the hypothalamic-pituitary-gonadal axis and the hypothalamic-pituitary-somatotropic (HPS) axis . In the gonadal axis, leptin administration stimulates GnRH release, which subsequently affects luteinizing hormone and follicle-stimulating hormone levels, influencing reproductive function . For the somatotropic axis, leptin influences growth hormone (GH) secretion in a season-dependent manner, with greater effects during short-day photoperiods . Unlike in rodents, leptin's effects on the hypothalamic-pituitary-thyroid and hypothalamic-pituitary-adrenal axes appear more limited in sheep, similar to findings in humans .

How does leptin influence growth hormone secretion differently based on photoperiod in sheep?

Research demonstrates a complex, photoperiod-dependent relationship between leptin and growth hormone secretion:

During Short-Day (SD) Photoperiod:

  • Leptin administration significantly increases GH secretion

  • Sheep exhibit physiological sensitivity to leptin

  • LEPR expression in the arcuate nucleus (ARC) is higher

During Long-Day (LD) Photoperiod:

  • The same dose of leptin fails to influence GH secretion

  • Sheep exhibit leptin resistance despite higher baseline leptin levels

  • LEPR expression in the ARC is lower

This differential response suggests a seasonal leptin resistance mechanism affecting the pituitary during LD periods, which appears to be targeted at post-transcriptional stages of GH secretion rather than transcriptional control . This represents an evolutionary adaptation allowing sheep to increase food intake despite elevated leptin levels when food is abundant.

What molecular mechanisms contribute to seasonal leptin resistance in sheep?

Several molecular mechanisms appear to contribute to seasonal leptin resistance in sheep:

  • Receptor expression: Lower leptin receptor (LEPR) mRNA expression in the arcuate nucleus during LD periods correlates with decreased leptin sensitivity

  • Hypothalamic regulation: Different patterns of LEPR expression in the paraventricular nucleus (PVN) in response to leptin treatment between seasons

  • Differential gene expression: Higher GHRH mRNA expression in the ARC and higher SST mRNA expression in the PVN during LD photoperiod

  • Regulatory effects: During SD photoperiod, leptin treatment increases LEPR expression in the PVN, while during LD photoperiod, leptin treatment decreases LEPR expression

This complex interplay creates a physiological adaptation allowing sheep to become resistant to leptin's anorectic action during periods of food abundance, representing a fundamentally different process than pathological leptin resistance in human obesity.

How does the expression of hypothalamic GHRH and SST genes relate to leptin's effects on GH secretion?

The relationship between hypothalamic gene expression and leptin's effects on GH secretion reveals region-specific patterns:

Hypothalamic StructureGeneControl SDLeptin SDControl LDLeptin LD
Arcuate nucleus (ARC)GHRH1 ± 0.08 A1.2 ± 0.04 A1.54 ± 0.11 B1.72 ± 0.14 B
LEPR1 ± 0.24 B0.95 ± 0.17 B0.58 ± 0.03 A0.66 ± 0.09 A
Paraventricular nucleus (PVN)SST1 ± 0.09 A1.17 ± 0.15 AB1.81 ± 0.4 B1.3 ± 0.19 AB
LEPR1 ± 0.13 B1.31 ± 0.11 C0.91 ± 0.03 B0.6 ± 0.08 A

GHRH mRNA expression in the ARC is significantly higher during LD photoperiod, while leptin administration does not significantly influence its expression in either photoperiod . SST mRNA expression in the PVN is also higher during long days. These patterns suggest that leptin's photoperiod-dependent effects on GH secretion likely involve post-transcriptional mechanisms rather than direct transcriptional regulation of GHRH or SST genes .

How should researchers design leptin administration studies in ovine models?

Based on established protocols, leptin administration studies in sheep should follow these methodological guidelines:

  • Animal selection:

    • Use adult ewes (2-3 years old)

    • Consider photoperiod conditions (specify SD or LD)

    • For SD studies, synchronize estrous cycles using intravaginal sponges (e.g., Chronogest CR)

    • Consider PMSG treatment (500 IU) 24 hours before experiments

  • Experimental setup:

    • Divide animals into control (saline) and experimental (leptin) groups

    • Maintain visual contact between animals

    • Ensure exposure to appropriate natural daylight

    • Fast animals for 12 hours before experiments

  • Leptin administration:

    • Use ovine recombinant leptin at approximately 20 μg/kg body weight

    • Administer intravenously in saline solution (0.9% w/v NaCl)

    • Begin sampling 1.5 hours pre-injection

    • Continue sampling for at least 2.5 hours post-injection at regular intervals

This design allows for rigorous assessment of leptin's effects while accounting for the critical photoperiod variable that significantly impacts results.

What molecular techniques are most appropriate for analyzing leptin effects in ovine tissues?

The molecular analysis of leptin effects in sheep studies should employ these techniques:

  • Tissue processing:

    • Rapid euthanasia (e.g., using Morbital at 80 mg/kg body weight)

    • Immediate collection and snap freezing of anterior pituitary and hypothalamic tissues

    • Storage at -80°C until analysis

  • RNA analysis workflow:

    • RNA isolation using specialized kits (e.g., NucleoSpin RNA/Protein kit)

    • Quality verification via spectrophotometry and gel electrophoresis

    • Reverse transcription using dedicated cDNA synthesis kits

    • Real-time PCR using appropriate reagents (e.g., HOT EvaGreen qPCR Mix)

  • Gene expression analysis:

    • Target genes should include GH, GHR, GHRH, GHRHR, SST, SSTR1-5, and LEPR

    • Use multiple reference genes (GAPDH, ACTB, HDAC1, B2M, PPIC)

    • Apply algorithms like NormFinder to identify optimal reference genes

    • Express results as ratios to reference genes with appropriate statistical analysis

The comprehensive primer set provided in the research (including sequences for all key target genes) provides a valuable resource for researchers pursuing these analyses.

How should researchers account for photoperiod effects when designing leptin studies in sheep?

When designing leptin studies in sheep, researchers must carefully consider these photoperiod-related factors:

  • Timing considerations:

    • Explicitly specify whether experiments are conducted during LD (May/June) or SD (November/December) conditions

    • Document natural daylight exposure during experimental periods

    • Consider that baseline leptin concentrations differ significantly between seasons

  • Physiological status:

    • Account for natural seasonal leptin resistance during LD periods

    • Remember that ewes are seasonally polyestrous (breeding during SD periods)

    • Only perform estrous synchronization during breeding season

  • Experimental design:

    • For comprehensive understanding, conduct parallel experiments in both photoperiods

    • Consider potential need for different leptin dosages based on seasonal sensitivity

    • Include appropriate controls for each photoperiod

    • Measure baseline hormone levels before intervention

Failure to account for these photoperiodic effects can lead to contradictory or uninterpretable results, as leptin's actions are fundamentally different between seasons.

How do leptin effects on neuroendocrine function differ between sheep and humans?

Important differences exist in leptin effects between sheep and humans:

Neuroendocrine SystemEffects in SheepEffects in Humans
Hypothalamic-pituitary-gonadalSeasonal regulation with pronounced effectsSignificant impacts on GnRH, LH, FSH production; administration restores menstruation in hypoleptinemic women
Hypothalamic-pituitary-somatotropicSeasonal variation in GH responseLimited direct effects on GH pulsatility; may alter IGF-1 secretion in men but not women
Hypothalamic-pituitary-thyroidMore pronounced effectsVery limited effects in humans
Hypothalamic-pituitary-adrenalMore significant impactsMinimal clinical importance
Leptin resistancePhysiological seasonal adaptationPathological state in obesity

These differences highlight why ovine models provide complementary insights to human studies, especially regarding seasonal adaptations in energy regulation and leptin sensitivity mechanisms .

What contradictions exist in the literature regarding leptin's effects on GH secretion?

Several notable contradictions exist in research findings regarding leptin's effects on GH secretion:

  • Species differences:

    • In rodents, leptin has significant effects on the GH-IGF axis

    • In humans, leptin's effects on GH pulsatility are minimal with limited clinical importance

    • In sheep, effects are pronounced but highly dependent on photoperiod

  • Seasonal variations:

    • Some studies report consistent leptin effects regardless of season

    • More recent research demonstrates fundamentally different responses between photoperiods

    • These contradictions may result from variations in experimental design, leptin dosage, or failure to account for baseline leptin differences

  • Central vs. peripheral effects:

    • Some research suggests primarily hypothalamic mechanisms

    • Other studies indicate direct pituitary effects

    • Current evidence suggests leptin influences GH secretion through multiple pathways with seasonal variations

These contradictions highlight the complexity of leptin's regulatory roles and the importance of carefully controlled experimental protocols that account for species differences and seasonal variables.

How can researchers effectively analyze gene expression data across multiple hypothalamic regions in leptin studies?

Effective analysis of gene expression data across multiple hypothalamic regions requires:

  • Reference gene optimization:

    • Test multiple reference genes (GAPDH, ACTB, HDAC1, B2M, PPIC)

    • Use algorithms like NormFinder to identify the most stable references for each region

    • Consider that reference gene stability may vary between brain regions and experimental conditions

  • Region-specific analysis:

    • Analyze each hypothalamic region separately before comparing across regions

    • Consider using different normalization strategies for different brain regions if reference gene stability varies

    • Account for functional differences between nuclei (e.g., ARC vs. PVN) when interpreting results

  • Data representation:

    • Express results as ratios to reference genes

    • Set a control condition (e.g., SD control group) as baseline (1.0)

    • Use statistical approaches that account for within-region and between-region variations

    • Present data in tables with clear statistical notation (as shown in Table 1 of the research)

This approach recognizes the functional specialization of hypothalamic nuclei while allowing for meaningful comparisons of leptin's effects across brain regions.

What are promising research areas for understanding leptin resistance mechanisms using ovine models?

Several promising research directions emerge from current knowledge:

  • Molecular signaling pathways:

    • Investigate post-receptor signaling components (SOCS3, PTP1B) in seasonal leptin resistance

    • Compare intracellular signaling cascades between SD and LD periods

    • Examine epigenetic mechanisms potentially regulating seasonal LEPR expression

  • Comparative physiology:

    • Design studies directly comparing pathological (diet-induced) and physiological (seasonal) leptin resistance

    • Investigate whether mechanisms overlap or diverge

    • Identify potential reversibility factors in seasonal resistance

  • Neural circuit mapping:

    • Map complete neural circuits mediating seasonal leptin effects on GH

    • Identify key interneurons and neurotransmitters involved

    • Compare circuit activation patterns between photoperiods

These approaches may yield insights applicable to understanding human leptin resistance while leveraging the unique seasonal adaptation of sheep as a natural experimental model.

How can findings from ovine leptin studies be translated to human metabolic research?

Translating findings from ovine leptin studies to human research requires:

  • Mechanistic focus:

    • Concentrate on shared molecular pathways rather than whole-system responses

    • Identify conserved signaling components between species

    • Focus on mechanisms of leptin resistance development and potential reversibility

  • Comparative approaches:

    • Design parallel studies in sheep and human tissues where possible

    • Conduct comparative analyses of leptin receptor variants and post-receptor signaling

    • Use ovine findings to generate testable hypotheses for human studies

  • Therapeutic implications:

    • Investigate whether seasonal transitions in sheep might suggest strategies for reversing pathological leptin resistance

    • Explore pharmacological agents that might mimic seasonal sensitivity changes

    • Consider leptin's interactions with other hormonal systems when designing human interventions

The physiological, reversible nature of ovine leptin resistance offers unique insights that complement studies of pathological resistance in human obesity.

What technological advances would enhance leptin research in large animal models?

Several technological advances would significantly advance leptin research in sheep and other large animal models:

  • Genetic tools:

    • Development of ovine-specific CRISPR-Cas9 protocols for targeted gene modification

    • Creation of reporter systems for real-time monitoring of leptin signaling

    • Establishment of conditional knockout models for key leptin pathway components

  • Imaging techniques:

    • Adaptation of functional MRI protocols for conscious sheep to map brain responses to leptin

    • Development of PET ligands specific for leptin receptors

    • Implementation of optogenetic or chemogenetic approaches in specific hypothalamic nuclei

  • High-throughput methodologies:

    • Single-cell RNA sequencing of hypothalamic populations to identify cell-specific responses

    • Proteomics and metabolomics approaches to map comprehensive leptin effects

    • Development of ovine-specific antibody arrays for signaling pathway analysis

Product Science Overview

Introduction

Leptin is a hormone predominantly made by adipose cells and enterocytes in the small intestine that helps to regulate energy balance by inhibiting hunger. Leptin acts on cell receptors in the arcuate nucleus of the hypothalamus. In recent years, researchers have developed various leptin antagonists to study and potentially treat conditions related to leptin signaling, such as obesity and metabolic disorders.

Leptin Antagonist Triple Mutant

The Leptin Antagonist Triple Mutant Ovine Recombinant, often referred to as Leptin tA Ovine, is a specially engineered protein designed to inhibit the action of leptin. This antagonist is a single non-glycosylated polypeptide chain containing 146 amino acids, with an additional alanine at the N-terminus. The molecular mass of this protein is approximately 16 kDa .

Mutations and Production

The Leptin Antagonist Triple Mutant is characterized by three specific mutations: L39A, D40A, and F41A. These mutations are introduced to disrupt the normal binding of leptin to its receptor, thereby inhibiting its biological activity. The protein is produced using recombinant DNA technology in Escherichia coli (E. coli) and is purified through proprietary chromatographic techniques .

Physical and Chemical Properties

The Leptin Antagonist Triple Mutant Ovine Recombinant is typically supplied as a white lyophilized (freeze-dried) powder. It is recommended to reconstitute the lyophilized protein in sterile water or sterile 0.4% NaHCO3 adjusted to pH 8, at a concentration of not less than 100 µg/ml. The protein is stable at room temperature for several weeks when lyophilized, but should be stored desiccated below -18°C for long-term storage .

Biological Activity

This leptin antagonist is capable of inhibiting leptin-induced proliferation of BAF/3 cells that are stably transfected with the long form of the mouse leptin receptor. It also inhibits various leptin effects in several in vitro bioassays. This makes it a valuable tool for studying leptin signaling pathways and for potential therapeutic applications in conditions where leptin activity needs to be modulated .

Applications and Research

Leptin antagonists, including the Leptin Antagonist Triple Mutant Ovine Recombinant, are used extensively in research to understand the role of leptin in energy homeostasis, obesity, and metabolic disorders. They are also being explored for their potential therapeutic applications in treating conditions such as obesity, diabetes, and other metabolic diseases .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.